Literature DB >> 16608123

Four year incidence of respiratory syncytial virus infection in infants and young children referred to emergency departments for lower respiratory tract diseases in Italy: the "Osservatorio VRS" Study (2000-2004).

Maria Cristina Medici1, Maria Cristina Arcangeletti, Giovanni A Rossi, Marcello Lanari, Rocco Merolla, Umberto Di Luzio Paparatti, Carlo Chezzi.   

Abstract

Respiratory Syncytial Virus (RSV) is a frequent cause of hospital admission in young children and high risk babies such as premature newborns, or babies with underlying cardiac or pulmonary disease, or immunodeficiency. Outbreaks occur most frequently in the cold season in areas with temperate and Mediterranean climates. Aim of the "Osservatorio VRS" Study was to describe the time-related pattern of RSV epidemics in Italy, across four consecutive epidemics, from 2000 to 2004. Nasal specimens for RSV detection were obtained and tested by an immunoenzymatic test. A total of 2110 children were tested for RSV determination, the rate of children with RSV infection was 21%, and that of children hospitalized for RSV disease was 49%. Considering the whole study period, the RSV epidemics started in October-November and ended in May, showing a peak incidence in February, with a median of 28.1% and a maximum of 48.9%. Analysis of monthly distribution of each year of the study showed a biennial trend for an earlier appearance. A different epidemiological pattern of the infection was observed among the three national areas. In conclusion, even though the mechanism governing RSV infection periodicity remains unknown, its awareness in the absence of an RSV surveillance system as in Italy, may be useful for scheduling RSV prophylaxis and for hospital resource management.

Entities:  

Mesh:

Year:  2006        PMID: 16608123

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  15 in total

Review 1.  Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age.

Authors:  X Carbonell-Estrany; L Bont; G Doering; J-B Gouyon; M Lanari
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-16       Impact factor: 3.267

2.  Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics.

Authors:  Giovanni A Rossi; Maria Cristina Medici; Maria Cristina Arcangeletti; Marcello Lanari; Rocco Merolla; Umberto Di Luzio Paparatti; Michela Silvestri; Angela Pistorio; Carlo Chezzi
Journal:  Eur J Pediatr       Date:  2007-02-17       Impact factor: 3.183

3.  Risk factors for bronchiolitis hospitalization during the first year of life in a multicenter Italian birth cohort.

Authors:  Marcello Lanari; Federica Prinelli; Fulvio Adorni; Simona Di Santo; Silvia Vandini; Michela Silvestri; Massimo Musicco
Journal:  Ital J Pediatr       Date:  2015-05-26       Impact factor: 2.638

4.  Prenatal tobacco smoke exposure increases hospitalizations for bronchiolitis in infants.

Authors:  Marcello Lanari; Silvia Vandini; Fulvio Adorni; Federica Prinelli; Simona Di Santo; Michela Silvestri; Massimo Musicco
Journal:  Respir Res       Date:  2015-12-22

Review 5.  Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries.

Authors:  Louis Bont; Paul A Checchia; Brigitte Fauroux; Josep Figueras-Aloy; Paolo Manzoni; Bosco Paes; Eric A F Simões; Xavier Carbonell-Estrany
Journal:  Infect Dis Ther       Date:  2016-08-01

Review 6.  Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease.

Authors:  Bosco Paes; Brigitte Fauroux; Josep Figueras-Aloy; Louis Bont; Paul A Checchia; Eric A F Simões; Paolo Manzoni; Xavier Carbonell-Estrany
Journal:  Infect Dis Ther       Date:  2016-11-18

7.  Epidemiological and clinical features of respiratory viral infections in hospitalized children during the circulation of influenza virus A(H1N1) 2009.

Authors:  Gianvincenzo Zuccotti; Dario Dilillo; Alessandra Zappa; Erica Galli; Antonella Amendola; Marianna Martinelli; Elena Pariani; Filippo Salvini; Elisabetta Tanzi; Enrica Riva; Marcello Giovannini
Journal:  Influenza Other Respir Viruses       Date:  2011-05-25       Impact factor: 4.380

8.  Respiratory Syncytial Virus-associated hospitalization in premature infants who did not receive palivizumab prophylaxis in Italy: a retrospective analysis from the Osservatorio Study.

Authors:  Michela Silvestri; Francesca Marando; Anna Maria Costanzo; Umberto di Luzio Paparatti; Giovanni A Rossi
Journal:  Ital J Pediatr       Date:  2016-04-26       Impact factor: 2.638

Review 9.  Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV).

Authors:  Lina Bollani; Eugenio Baraldi; Gaetano Chirico; Andrea Dotta; Marcello Lanari; Antonello Del Vecchio; Paolo Manzoni; Antonio Boldrini; Piermichele Paolillo; Sandra Di Fabio; Luigi Orfeo; Mauro Stronati; Costantino Romagnoli
Journal:  Ital J Pediatr       Date:  2015-12-15       Impact factor: 2.638

10.  Human respiratory syncytial virus and hospitalization in young children in Italy.

Authors:  Parvanè Kuhdari; Federica Brosio; Cristina Malaventura; Armando Stefanati; Andrea Orsi; Giancarlo Icardi; Giovanni Gabutti
Journal:  Ital J Pediatr       Date:  2018-05-04       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.